Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDQuarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 1 | -$2.26 | -$2.26 | -$2.26 |
Q2 2024 | 1 | -$1.70 | -$1.70 | -$1.70 |
Q3 2024 | 1 | -$0.81 | -$0.81 | -$0.81 |
Q4 2024 | 1 | -$0.73 | -$0.73 | -$0.73 |
Q1 2025 | 1 | -$0.43 | -$0.43 | -$0.43 |
Q2 2025 | 1 | -$0.33 | -$0.33 | -$0.33 |
Q3 2025 | 1 | -$0.28 | -$0.28 | -$0.28 |
Q4 2025 | 1 | -$0.29 | -$0.29 | -$0.29 |
TFF Pharmaceuticals, Inc. last posted its earnings results on Wednesday, November 20th, 2024. The company reported $-0.81 earnings per share for the quarter, missing analysts' consensus estimates of $-0.81 by $0. The company had revenue of 193,387 for the quarter and had revenue of 733,871 for the year. TFF Pharmaceuticals, Inc. has generated $-12 earnings per share over the last year ($-11.85 diluted earnings per share) and currently has a price-to-earnings ratio of -0.02. TFF Pharmaceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 20th, 2024 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
11/20/2024 | Q3 2024 | -$0.81 | -$0.81 | 0 | $150,000 | $193,387 |
08/14/2024 | Q2 2024 | -$1.70 | -$1.22 | 0.48 | $150,000 | $650,222 |
05/14/2024 | Q1 2024 | -$2.20 | -$2.40 | -0.2 | $203,273 | |
03/28/2024 | Q4 2023 | -$2.00 | -$2.01 | -0.01 | $733,871 | |
11/14/2023 | Q3 2023 | -$2.75 | -$2.32 | 0.43 | $50,000 | $0 |
08/14/2023 | Q2 2023 | -$3.47 | $66,667 | $333,351 | ||
05/11/2023 | Q1 2023 | -$5.00 | -$4.76 | 0.24 | $51,429 | |
03/31/2023 | Q4 2022 | -$5.10 | $0 | |||
11/14/2022 | Q3 2022 | -$7.75 | -$0.29 | 7.46 | $0 | |
08/11/2022 | Q2 2022 | -$8.00 | -$0.34 | 7.66 | $0 | |
05/11/2022 | Q1 2022 | -$9.50 | -$0.33 | 9.17 | $0 | |
03/24/2022 | Q4 2021 | -$7.50 | -$0.40 | 7.1 | $0 | |
11/15/2021 | Q3 2021 | -$3.50 | -$0.34 | 3.16 | $1.70 M | $0 |
08/12/2021 | Q2 2021 | -$7.00 | -$0.18 | 6.82 | $0 | |
05/13/2021 | Q1 2021 | -$6.00 | -$0.33 | 5.67 | $0 | |
03/10/2021 | Q4 2020 | -$5.75 | -$0.26 | 5.49 | $0 | |
11/05/2020 | Q3 2020 | -$5.00 | -$0.24 | 4.76 | $500,000 | $0 |
08/13/2020 | Q2 2020 | -$5.25 | -$0.20 | 5.05 | $0 | |
05/14/2020 | Q1 2020 | -$6.00 | -$0.20 | 5.8 | $0 | |
03/26/2020 | Q4 2019 | -$0.33 | $0 |
TFF Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 20th, 2024 based off last year's report dates.
The conference call for TFF Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
The conference call transcript for TFF Pharmaceuticals, Inc.'s latest earnings report can be read online.
TFF Pharmaceuticals, Inc. (:TFFP) has a recorded annual revenue of $733,871.
TFF Pharmaceuticals, Inc. (:TFFP) has a recorded net income of $733,871. TFF Pharmaceuticals, Inc. has generated $-11.85 earnings per share over the last four quarters.
TFF Pharmaceuticals, Inc. (:TFFP) has a price-to-earnings ratio of -0.02 and price/earnings-to-growth ratio is -0.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED